Skip to content
CancerIndex

Loading the knowledge graph…

A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Diffuse Non-Hodgkin Lymphoma — knowledge graph · CancerIndex